Clinical Trial Update: STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tranexamic acid for preventing hematoma growth after intracerebral hemorrhage; trial completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage
• Stroke

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Neuroscience Trials Australia | Conditions: Intracerebral Haemorrhage, Stroke | Phase 2 | Status: COMPLETED